|
Home
|
E-Submission
|
Sitemap
|
Contact Us
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
J Korean Cancer Assoc
>
Volume 25(5); 1993
> Article
Original Article
Journal of the Korean Cancer Association 1993;25(5): 725-735.
Phase II clinical trial of recombinant human granulocyte colony-stimulating factor(fhG-CSF)(KRN8601) in advanced cancer patients with myelosuppression after chemotherapy
Jae Kyung Roh
,
Jin Hyuk Choi
,
Kyung Hee Lee
,
Hye Ran Lee
,
Nae Choon Yoo
,
Joo Hang Kim
,
Byung Soo Kim
,
Ho Young Lim
ABSTRACT
No abstract available.
TOOLS
PDF Links
Full text via DOI
Download Citation
Share:
METRICS
2,526
View
15
Download
Related articles
A Phase 3 Clinical Trial of Recombinant Human Granulocyte - Macrophage Colony Stimulating
1995 ;27(5)
A Phase 2 Clinical Trial of Recombinant Human Granulocyte Macrophage Colony Stimulatin
1995 ;27(3)
Efficacy of recombinant human granulocyte colony-stimulating factor(neutrogin) for chemotherapy induced neutropenia in patients with advanced lung carcinoma
1993 April;25(2)
Phase I study of subcutaneously administered recombinant human granulocyte-macrophage colony stimulating factor(GM-CSF) in patients with advanced malignancy
1993 August;25(4)
The Efficacy and Safety of DA-3030 (Recombinant Human Granulocyte Colony-Stimulating Factor) in Neutropenia after the Remission Induction Chemotherapy in Patients with Acute Myelogenous Leukemia
2003 February;35(1)
PDF Links
Full text via DOI 
Download Citation 
